TD Cowen Downgrades agilon health Inc (AGL) to Market Perform, 'Risk Flows Downhill'

TD Cowen analyst Gary Taylor downgraded agilon health Inc (NYSE: AGL) from Outperform to Market Perform with a price target of $6.50 (from $12.00).

The analyst comments "In January, AGL guided 2024 EBITDA 50% below, withdrew 2026 and announced its CFO’s retirement. As the stock plunged below 0.4x 2025 EV/Sales, we chose to maintain our Outperform rating due to perceived strategic value (even with Street-low estimates). We now know AGL’s largest payor partners did not properly underwrite 2024 MA risk; this incremental margin risk will flow downhill to AGL."

For an analyst ratings summary and ratings history on agilon health Inc click here. For more ratings news on agilon health Inc click here.

Shares of agilon health Inc closed at $6.27 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• New Street Research Upgrades Micron Technology (MU) to Buy
• LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities